カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の経皮治療システム（TTS）市場2022年：サリチル酸メチル、ニトログリセリン、フェンタニル、ニコチン、リバスチグミン、エストラジオール、その他

◆英語タイトル：Global Transdermal Therapeutic Systems (TTS) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8977 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：120 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

経皮治療システム（TTS）市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の経皮治療システム（TTS）の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

経皮治療システム（TTS）市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・サリチル酸メチル、ニトログリセリン、フェンタニル、ニコチン、リバスチグミン、エストラジオール、その他

用途別セグメントは次のように区分されます。
・OTCチャネル、小売チャネル、Eコマースチャネル

世界の経皮治療システム（TTS）市場の主要な市場プレーヤーは以下のとおりです。
・Hisamitsu、Mylan、GSK、Novartis、Teve (Actavis)、Nitto Denko、Johnson & Johnson、Lohmann、Teikoku Seiyaku、Pfizer、Bayer、Lingrui、Sanofi、UCB Pharma、Dr. Reddy's Laboratories、Qizheng、Endo、Mundipharma、Huarun 999、Haw Par、Nichiban、Mentholatum Company、Laboratoires Genevrier、Beijing Tide Pharmaceutical、Luye Pharma Group

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、経皮治療システム（TTS）製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な経皮治療システム（TTS）メーカーの企業概要、2019年～2022年までの経皮治療システム（TTS）の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な経皮治療システム（TTS）メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別経皮治療システム（TTS）の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの経皮治療システム（TTS）の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での経皮治療システム（TTS）市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および経皮治療システム（TTS）の産業チェーンを掲載しています。
・第13、14、15章では、経皮治療システム（TTS）の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Hisamitsu、Mylan、GSK、Novartis、Teve (Actavis)、Nitto Denko、Johnson & Johnson、Lohmann、Teikoku Seiyaku、Pfizer、Bayer、Lingrui、Sanofi、UCB Pharma、Dr. Reddy's Laboratories、Qizheng、Endo、Mundipharma、Huarun 999、Haw Par、Nichiban、Mentholatum Company、Laboratoires Genevrier、Beijing Tide Pharmaceutical、Luye Pharma Group
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：サリチル酸メチル、ニトログリセリン、フェンタニル、ニコチン、リバスチグミン、エストラジオール、その他
・用途別分析2017年-2028年：OTCチャネル、小売チャネル、Eコマースチャネル
・経皮治療システム（TTS）の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・経皮治療システム（TTS）のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・経皮治療システム（TTS）のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・経皮治療システム（TTS）の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・経皮治療システム（TTS）の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Transdermal Therapeutic Systems (TTS) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Transdermal Therapeutic Systems (TTS) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. OTC Channel accounting for % of the Transdermal Therapeutic Systems (TTS) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Methyl Salicylate segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Transdermal Therapeutic Systems (TTS) include Hisamitsu, Mylan, GSK, Novartis, and Teve (Actavis), etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Transdermal Therapeutic Systems (TTS) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Methyl Salicylate
Nitroglycerin
Fentanyl
Nicotine
Rivastigmine
Estradiol
Others
Market segment by Application can be divided into
OTC Channel
Retail Channel
E-Commerce Channel
The key market players for global Transdermal Therapeutic Systems (TTS) market are listed below:
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Nitto Denko
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Pfizer
Bayer
Lingrui
Sanofi
UCB Pharma
Dr. Reddy’s Laboratories
Qizheng
Endo
Mundipharma
Huarun 999
Haw Par
Nichiban
Mentholatum Company
Laboratoires Genevrier
Beijing Tide Pharmaceutical
Luye Pharma Group
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Transdermal Therapeutic Systems (TTS) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Transdermal Therapeutic Systems (TTS), with price, sales, revenue and global market share of Transdermal Therapeutic Systems (TTS) from 2019 to 2022.
Chapter 3, the Transdermal Therapeutic Systems (TTS) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transdermal Therapeutic Systems (TTS) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Transdermal Therapeutic Systems (TTS) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Transdermal Therapeutic Systems (TTS).
Chapter 13, 14, and 15, to describe Transdermal Therapeutic Systems (TTS) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Transdermal Therapeutic Systems (TTS) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Transdermal Therapeutic Systems (TTS) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Methyl Salicylate
1.2.3 Nitroglycerin
1.2.4 Fentanyl
1.2.5 Nicotine
1.2.6 Rivastigmine
1.2.7 Estradiol
1.2.8 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Transdermal Therapeutic Systems (TTS) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 OTC Channel
1.3.3 Retail Channel
1.3.4 E-Commerce Channel
1.4 Global Transdermal Therapeutic Systems (TTS) Market Size & Forecast
1.4.1 Global Transdermal Therapeutic Systems (TTS) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Transdermal Therapeutic Systems (TTS) Sales in Volume (2017-2028)
1.4.3 Global Transdermal Therapeutic Systems (TTS) Price (2017-2028)
1.5 Global Transdermal Therapeutic Systems (TTS) Production Capacity Analysis
1.5.1 Global Transdermal Therapeutic Systems (TTS) Total Production Capacity (2017-2028)
1.5.2 Global Transdermal Therapeutic Systems (TTS) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Transdermal Therapeutic Systems (TTS) Market Drivers
1.6.2 Transdermal Therapeutic Systems (TTS) Market Restraints
1.6.3 Transdermal Therapeutic Systems (TTS) Trends Analysis
2 Manufacturers Profiles
2.1 Hisamitsu
2.1.1 Hisamitsu Details
2.1.2 Hisamitsu Major Business
2.1.3 Hisamitsu Transdermal Therapeutic Systems (TTS) Product and Services
2.1.4 Hisamitsu Transdermal Therapeutic Systems (TTS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business
2.2.3 Mylan Transdermal Therapeutic Systems (TTS) Product and Services
2.2.4 Mylan Transdermal Therapeutic Systems (TTS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Transdermal Therapeutic Systems (TTS) Product and Services
2.3.4 GSK Transdermal Therapeutic Systems (TTS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Transdermal Therapeutic Systems (TTS) Product and Services
2.4.4 Novartis Transdermal Therapeutic Systems (TTS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Teve (Actavis)
2.5.1 Teve (Actavis) Details
2.5.2 Teve (Actavis) Major Business
2.5.3 Teve (Actavis) Transdermal Therapeutic Systems (TTS) Product and Services
2.5.4 Teve (Actavis) Transdermal Therapeutic Systems (TTS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Nitto Denko
2.6.1 Nitto Denko Details
2.6.2 Nitto Denko Major Business
2.6.3 Nitto Denko Transdermal Therapeutic Systems (TTS) Product and Services
2.6.4 Nitto Denko Transdermal Therapeutic Systems (TTS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business
2.7.3 Johnson & Johnson Transdermal Therapeutic Systems (TTS) Product and Services
2.7.4 Johnson & Johnson Transdermal Therapeutic Systems (TTS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Lohmann
2.8.1 Lohmann Details
2.8.2 Lohmann Major Business
2.8.3 Lohmann Transdermal Therapeutic Systems (TTS) Product and Services
2.8.4 Lohmann Transdermal Therapeutic Systems (TTS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Teikoku Seiyaku
2.9.1 Teikoku Seiyaku Details
2.9.2 Teikoku Seiyaku Major Business
2.9.3 Teikoku Seiyaku Transdermal Therapeutic Systems (TTS) Product and Services
2.9.4 Teikoku Seiyaku Transdermal Therapeutic Systems (TTS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Transdermal Therapeutic Systems (TTS) Product and Services
2.10.4 Pfizer Transdermal Therapeutic Systems (TTS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Bayer
2.11.1 Bayer Details
2.11.2 Bayer Major Business
2.11.3 Bayer Transdermal Therapeutic Systems (TTS) Product and Services
2.11.4 Bayer Transdermal Therapeutic Systems (TTS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Lingrui
2.12.1 Lingrui Details
2.12.2 Lingrui Major Business
2.12.3 Lingrui Transdermal Therapeutic Systems (TTS) Product and Services
2.12.4 Lingrui Transdermal Therapeutic Systems (TTS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Sanofi
2.13.1 Sanofi Details
2.13.2 Sanofi Major Business
2.13.3 Sanofi Transdermal Therapeutic Systems (TTS) Product and Services
2.13.4 Sanofi Transdermal Therapeutic Systems (TTS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 UCB Pharma
2.14.1 UCB Pharma Details
2.14.2 UCB Pharma Major Business
2.14.3 UCB Pharma Transdermal Therapeutic Systems (TTS) Product and Services
2.14.4 UCB Pharma Transdermal Therapeutic Systems (TTS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Dr. Reddy’s Laboratories
2.15.1 Dr. Reddy’s Laboratories Details
2.15.2 Dr. Reddy’s Laboratories Major Business
2.15.3 Dr. Reddy’s Laboratories Transdermal Therapeutic Systems (TTS) Product and Services
2.15.4 Dr. Reddy’s Laboratories Transdermal Therapeutic Systems (TTS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Qizheng
2.16.1 Qizheng Details
2.16.2 Qizheng Major Business
2.16.3 Qizheng Transdermal Therapeutic Systems (TTS) Product and Services
2.16.4 Qizheng Transdermal Therapeutic Systems (TTS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Endo
2.17.1 Endo Details
2.17.2 Endo Major Business
2.17.3 Endo Transdermal Therapeutic Systems (TTS) Product and Services
2.17.4 Endo Transdermal Therapeutic Systems (TTS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Mundipharma
2.18.1 Mundipharma Details
2.18.2 Mundipharma Major Business
2.18.3 Mundipharma Transdermal Therapeutic Systems (TTS) Product and Services
2.18.4 Mundipharma Transdermal Therapeutic Systems (TTS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Huarun 999
2.19.1 Huarun 999 Details
2.19.2 Huarun 999 Major Business
2.19.3 Huarun 999 Transdermal Therapeutic Systems (TTS) Product and Services
2.19.4 Huarun 999 Transdermal Therapeutic Systems (TTS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Haw Par
2.20.1 Haw Par Details
2.20.2 Haw Par Major Business
2.20.3 Haw Par Transdermal Therapeutic Systems (TTS) Product and Services
2.20.4 Haw Par Transdermal Therapeutic Systems (TTS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 Nichiban
2.21.1 Nichiban Details
2.21.2 Nichiban Major Business
2.21.3 Nichiban Transdermal Therapeutic Systems (TTS) Product and Services
2.21.4 Nichiban Transdermal Therapeutic Systems (TTS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22 Mentholatum Company
2.22.1 Mentholatum Company Details
2.22.2 Mentholatum Company Major Business
2.22.3 Mentholatum Company Transdermal Therapeutic Systems (TTS) Product and Services
2.22.4 Mentholatum Company Transdermal Therapeutic Systems (TTS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23 Laboratoires Genevrier
2.23.1 Laboratoires Genevrier Details
2.23.2 Laboratoires Genevrier Major Business
2.23.3 Laboratoires Genevrier Transdermal Therapeutic Systems (TTS) Product and Services
2.23.4 Laboratoires Genevrier Transdermal Therapeutic Systems (TTS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.24 Beijing Tide Pharmaceutical
2.24.1 Beijing Tide Pharmaceutical Details
2.24.2 Beijing Tide Pharmaceutical Major Business
2.24.3 Beijing Tide Pharmaceutical Transdermal Therapeutic Systems (TTS) Product and Services
2.24.4 Beijing Tide Pharmaceutical Transdermal Therapeutic Systems (TTS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.25 Luye Pharma Group
2.25.1 Luye Pharma Group Details
2.25.2 Luye Pharma Group Major Business
2.25.3 Luye Pharma Group Transdermal Therapeutic Systems (TTS) Product and Services
2.25.4 Luye Pharma Group Transdermal Therapeutic Systems (TTS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Transdermal Therapeutic Systems (TTS) Breakdown Data by Manufacturer
3.1 Global Transdermal Therapeutic Systems (TTS) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Transdermal Therapeutic Systems (TTS) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Transdermal Therapeutic Systems (TTS)
3.4 Market Concentration Rate
3.4.1 Top 3 Transdermal Therapeutic Systems (TTS) Manufacturer Market Share in 2021
3.4.2 Top 6 Transdermal Therapeutic Systems (TTS) Manufacturer Market Share in 2021
3.5 Global Transdermal Therapeutic Systems (TTS) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Transdermal Therapeutic Systems (TTS) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Transdermal Therapeutic Systems (TTS) Market Size by Region
4.1.1 Global Transdermal Therapeutic Systems (TTS) Sales in Volume by Region (2017-2028)
4.1.2 Global Transdermal Therapeutic Systems (TTS) Revenue by Region (2017-2028)
4.2 North America Transdermal Therapeutic Systems (TTS) Revenue (2017-2028)
4.3 Europe Transdermal Therapeutic Systems (TTS) Revenue (2017-2028)
4.4 Asia-Pacific Transdermal Therapeutic Systems (TTS) Revenue (2017-2028)
4.5 South America Transdermal Therapeutic Systems (TTS) Revenue (2017-2028)
4.6 Middle East and Africa Transdermal Therapeutic Systems (TTS) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Transdermal Therapeutic Systems (TTS) Sales in Volume by Type (2017-2028)
5.2 Global Transdermal Therapeutic Systems (TTS) Revenue by Type (2017-2028)
5.3 Global Transdermal Therapeutic Systems (TTS) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Transdermal Therapeutic Systems (TTS) Sales in Volume by Application (2017-2028)
6.2 Global Transdermal Therapeutic Systems (TTS) Revenue by Application (2017-2028)
6.3 Global Transdermal Therapeutic Systems (TTS) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Transdermal Therapeutic Systems (TTS) Sales by Type (2017-2028)
7.2 North America Transdermal Therapeutic Systems (TTS) Sales by Application (2017-2028)
7.3 North America Transdermal Therapeutic Systems (TTS) Market Size by Country
7.3.1 North America Transdermal Therapeutic Systems (TTS) Sales in Volume by Country (2017-2028)
7.3.2 North America Transdermal Therapeutic Systems (TTS) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Transdermal Therapeutic Systems (TTS) Sales by Type (2017-2028)
8.2 Europe Transdermal Therapeutic Systems (TTS) Sales by Application (2017-2028)
8.3 Europe Transdermal Therapeutic Systems (TTS) Market Size by Country
8.3.1 Europe Transdermal Therapeutic Systems (TTS) Sales in Volume by Country (2017-2028)
8.3.2 Europe Transdermal Therapeutic Systems (TTS) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Transdermal Therapeutic Systems (TTS) Sales by Type (2017-2028)
9.2 Asia-Pacific Transdermal Therapeutic Systems (TTS) Sales by Application (2017-2028)
9.3 Asia-Pacific Transdermal Therapeutic Systems (TTS) Market Size by Region
9.3.1 Asia-Pacific Transdermal Therapeutic Systems (TTS) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Transdermal Therapeutic Systems (TTS) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Transdermal Therapeutic Systems (TTS) Sales by Type (2017-2028)
10.2 South America Transdermal Therapeutic Systems (TTS) Sales by Application (2017-2028)
10.3 South America Transdermal Therapeutic Systems (TTS) Market Size by Country
10.3.1 South America Transdermal Therapeutic Systems (TTS) Sales in Volume by Country (2017-2028)
10.3.2 South America Transdermal Therapeutic Systems (TTS) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Transdermal Therapeutic Systems (TTS) Sales by Type (2017-2028)
11.2 Middle East & Africa Transdermal Therapeutic Systems (TTS) Sales by Application (2017-2028)
11.3 Middle East & Africa Transdermal Therapeutic Systems (TTS) Market Size by Country
11.3.1 Middle East & Africa Transdermal Therapeutic Systems (TTS) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Transdermal Therapeutic Systems (TTS) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Transdermal Therapeutic Systems (TTS) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Transdermal Therapeutic Systems (TTS)
12.3 Transdermal Therapeutic Systems (TTS) Production Process
12.4 Transdermal Therapeutic Systems (TTS) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Transdermal Therapeutic Systems (TTS) Typical Distributors
13.3 Transdermal Therapeutic Systems (TTS) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Transdermal Therapeutic Systems (TTS) Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Transdermal Therapeutic Systems (TTS) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Hisamitsu Basic Information, Manufacturing Base and Competitors
Table 4. Hisamitsu Major Business
Table 5. Hisamitsu Transdermal Therapeutic Systems (TTS) Product and Services
Table 6. Hisamitsu Transdermal Therapeutic Systems (TTS) Sales (M Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Mylan Basic Information, Manufacturing Base and Competitors
Table 8. Mylan Major Business
Table 9. Mylan Transdermal Therapeutic Systems (TTS) Product and Services
Table 10. Mylan Transdermal Therapeutic Systems (TTS) Sales (M Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. GSK Basic Information, Manufacturing Base and Competitors
Table 12. GSK Major Business
Table 13. GSK Transdermal Therapeutic Systems (TTS) Product and Services
Table 14. GSK Transdermal Therapeutic Systems (TTS) Sales (M Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Novartis Basic Information, Manufacturing Base and Competitors
Table 16. Novartis Major Business
Table 17. Novartis Transdermal Therapeutic Systems (TTS) Product and Services
Table 18. Novartis Transdermal Therapeutic Systems (TTS) Sales (M Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Teve (Actavis) Basic Information, Manufacturing Base and Competitors
Table 20. Teve (Actavis) Major Business
Table 21. Teve (Actavis) Transdermal Therapeutic Systems (TTS) Product and Services
Table 22. Teve (Actavis) Transdermal Therapeutic Systems (TTS) Sales (M Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Nitto Denko Basic Information, Manufacturing Base and Competitors
Table 24. Nitto Denko Major Business
Table 25. Nitto Denko Transdermal Therapeutic Systems (TTS) Product and Services
Table 26. Nitto Denko Transdermal Therapeutic Systems (TTS) Sales (M Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 28. Johnson & Johnson Major Business
Table 29. Johnson & Johnson Transdermal Therapeutic Systems (TTS) Product and Services
Table 30. Johnson & Johnson Transdermal Therapeutic Systems (TTS) Sales (M Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Lohmann Basic Information, Manufacturing Base and Competitors
Table 32. Lohmann Major Business
Table 33. Lohmann Transdermal Therapeutic Systems (TTS) Product and Services
Table 34. Lohmann Transdermal Therapeutic Systems (TTS) Sales (M Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Teikoku Seiyaku Basic Information, Manufacturing Base and Competitors
Table 36. Teikoku Seiyaku Major Business
Table 37. Teikoku Seiyaku Transdermal Therapeutic Systems (TTS) Product and Services
Table 38. Teikoku Seiyaku Transdermal Therapeutic Systems (TTS) Sales (M Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Pfizer Basic Information, Manufacturing Base and Competitors
Table 40. Pfizer Major Business
Table 41. Pfizer Transdermal Therapeutic Systems (TTS) Product and Services
Table 42. Pfizer Transdermal Therapeutic Systems (TTS) Sales (M Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Bayer Basic Information, Manufacturing Base and Competitors
Table 44. Bayer Major Business
Table 45. Bayer Transdermal Therapeutic Systems (TTS) Product and Services
Table 46. Bayer Transdermal Therapeutic Systems (TTS) Sales (M Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Lingrui Basic Information, Manufacturing Base and Competitors
Table 48. Lingrui Major Business
Table 49. Lingrui Transdermal Therapeutic Systems (TTS) Product and Services
Table 50. Lingrui Transdermal Therapeutic Systems (TTS) Sales (M Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Sanofi Basic Information, Manufacturing Base and Competitors
Table 52. Sanofi Major Business
Table 53. Sanofi Transdermal Therapeutic Systems (TTS) Product and Services
Table 54. Sanofi Transdermal Therapeutic Systems (TTS) Sales (M Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. UCB Pharma Basic Information, Manufacturing Base and Competitors
Table 56. UCB Pharma Major Business
Table 57. UCB Pharma Transdermal Therapeutic Systems (TTS) Product and Services
Table 58. UCB Pharma Transdermal Therapeutic Systems (TTS) Sales (M Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 60. Dr. Reddy's Laboratories Major Business
Table 61. Dr. Reddy's Laboratories Transdermal Therapeutic Systems (TTS) Product and Services
Table 62. Dr. Reddy's Laboratories Transdermal Therapeutic Systems (TTS) Sales (M Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Qizheng Basic Information, Manufacturing Base and Competitors
Table 64. Qizheng Major Business
Table 65. Qizheng Transdermal Therapeutic Systems (TTS) Product and Services
Table 66. Qizheng Transdermal Therapeutic Systems (TTS) Sales (M Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Endo Basic Information, Manufacturing Base and Competitors
Table 68. Endo Major Business
Table 69. Endo Transdermal Therapeutic Systems (TTS) Product and Services
Table 70. Endo Transdermal Therapeutic Systems (TTS) Sales (M Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 72. Mundipharma Major Business
Table 73. Mundipharma Transdermal Therapeutic Systems (TTS) Product and Services
Table 74. Mundipharma Transdermal Therapeutic Systems (TTS) Sales (M Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Huarun 999 Basic Information, Manufacturing Base and Competitors
Table 76. Huarun 999 Major Business
Table 77. Huarun 999 Transdermal Therapeutic Systems (TTS) Product and Services
Table 78. Huarun 999 Transdermal Therapeutic Systems (TTS) Sales (M Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Haw Par Basic Information, Manufacturing Base and Competitors
Table 80. Haw Par Major Business
Table 81. Haw Par Transdermal Therapeutic Systems (TTS) Product and Services
Table 82. Haw Par Transdermal Therapeutic Systems (TTS) Sales (M Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Nichiban Basic Information, Manufacturing Base and Competitors
Table 84. Nichiban Major Business
Table 85. Nichiban Transdermal Therapeutic Systems (TTS) Product and Services
Table 86. Nichiban Transdermal Therapeutic Systems (TTS) Sales (M Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 87. Mentholatum Company Basic Information, Manufacturing Base and Competitors
Table 88. Mentholatum Company Major Business
Table 89. Mentholatum Company Transdermal Therapeutic Systems (TTS) Product and Services
Table 90. Mentholatum Company Transdermal Therapeutic Systems (TTS) Sales (M Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 91. Laboratoires Genevrier Basic Information, Manufacturing Base and Competitors
Table 92. Laboratoires Genevrier Major Business
Table 93. Laboratoires Genevrier Transdermal Therapeutic Systems (TTS) Product and Services
Table 94. Laboratoires Genevrier Transdermal Therapeutic Systems (TTS) Sales (M Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 95. Beijing Tide Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 96. Beijing Tide Pharmaceutical Major Business
Table 97. Beijing Tide Pharmaceutical Transdermal Therapeutic Systems (TTS) Product and Services
Table 98. Beijing Tide Pharmaceutical Transdermal Therapeutic Systems (TTS) Sales (M Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 99. Luye Pharma Group Basic Information, Manufacturing Base and Competitors
Table 100. Luye Pharma Group Major Business
Table 101. Luye Pharma Group Transdermal Therapeutic Systems (TTS) Product and Services
Table 102. Luye Pharma Group Transdermal Therapeutic Systems (TTS) Sales (M Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 103. Global Transdermal Therapeutic Systems (TTS) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (M Units)
Table 104. Global Transdermal Therapeutic Systems (TTS) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 105. Market Position of Manufacturers in Transdermal Therapeutic Systems (TTS), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 106. Global Transdermal Therapeutic Systems (TTS) Production Capacity by Company, (M Units): 2020 VS 2021
Table 107. Head Office and Transdermal Therapeutic Systems (TTS) Production Site of Key Manufacturer
Table 108. Transdermal Therapeutic Systems (TTS) New Entrant and Capacity Expansion Plans
Table 109. Transdermal Therapeutic Systems (TTS) Mergers & Acquisitions in the Past Five Years
Table 110. Global Transdermal Therapeutic Systems (TTS) Sales by Region (2017-2022) & (M Units)
Table 111. Global Transdermal Therapeutic Systems (TTS) Sales by Region (2023-2028) & (M Units)
Table 112. Global Transdermal Therapeutic Systems (TTS) Revenue by Region (2017-2022) & (USD Million)
Table 113. Global Transdermal Therapeutic Systems (TTS) Revenue by Region (2023-2028) & (USD Million)
Table 114. Global Transdermal Therapeutic Systems (TTS) Sales by Type (2017-2022) & (M Units)
Table 115. Global Transdermal Therapeutic Systems (TTS) Sales by Type (2023-2028) & (M Units)
Table 116. Global Transdermal Therapeutic Systems (TTS) Revenue by Type (2017-2022) & (USD Million)
Table 117. Global Transdermal Therapeutic Systems (TTS) Revenue by Type (2023-2028) & (USD Million)
Table 118. Global Transdermal Therapeutic Systems (TTS) Price by Type (2017-2022) & (USD/K Units)
Table 119. Global Transdermal Therapeutic Systems (TTS) Price by Type (2023-2028) & (USD/K Units)
Table 120. Global Transdermal Therapeutic Systems (TTS) Sales by Application (2017-2022) & (M Units)
Table 121. Global Transdermal Therapeutic Systems (TTS) Sales by Application (2023-2028) & (M Units)
Table 122. Global Transdermal Therapeutic Systems (TTS) Revenue by Application (2017-2022) & (USD Million)
Table 123. Global Transdermal Therapeutic Systems (TTS) Revenue by Application (2023-2028) & (USD Million)
Table 124. Global Transdermal Therapeutic Systems (TTS) Price by Application (2017-2022) & (USD/K Units)
Table 125. Global Transdermal Therapeutic Systems (TTS) Price by Application (2023-2028) & (USD/K Units)
Table 126. North America Transdermal Therapeutic Systems (TTS) Sales by Country (2017-2022) & (M Units)
Table 127. North America Transdermal Therapeutic Systems (TTS) Sales by Country (2023-2028) & (M Units)
Table 128. North America Transdermal Therapeutic Systems (TTS) Revenue by Country (2017-2022) & (USD Million)
Table 129. North America Transdermal Therapeutic Systems (TTS) Revenue by Country (2023-2028) & (USD Million)
Table 130. North America Transdermal Therapeutic Systems (TTS) Sales by Type (2017-2022) & (M Units)
Table 131. North America Transdermal Therapeutic Systems (TTS) Sales by Type (2023-2028) & (M Units)
Table 132. North America Transdermal Therapeutic Systems (TTS) Sales by Application (2017-2022) & (M Units)
Table 133. North America Transdermal Therapeutic Systems (TTS) Sales by Application (2023-2028) & (M Units)
Table 134. Europe Transdermal Therapeutic Systems (TTS) Sales by Country (2017-2022) & (M Units)
Table 135. Europe Transdermal Therapeutic Systems (TTS) Sales by Country (2023-2028) & (M Units)
Table 136. Europe Transdermal Therapeutic Systems (TTS) Revenue by Country (2017-2022) & (USD Million)
Table 137. Europe Transdermal Therapeutic Systems (TTS) Revenue by Country (2023-2028) & (USD Million)
Table 138. Europe Transdermal Therapeutic Systems (TTS) Sales by Type (2017-2022) & (M Units)
Table 139. Europe Transdermal Therapeutic Systems (TTS) Sales by Type (2023-2028) & (M Units)
Table 140. Europe Transdermal Therapeutic Systems (TTS) Sales by Application (2017-2022) & (M Units)
Table 141. Europe Transdermal Therapeutic Systems (TTS) Sales by Application (2023-2028) & (M Units)
Table 142. Asia-Pacific Transdermal Therapeutic Systems (TTS) Sales by Region (2017-2022) & (M Units)
Table 143. Asia-Pacific Transdermal Therapeutic Systems (TTS) Sales by Region (2023-2028) & (M Units)
Table 144. Asia-Pacific Transdermal Therapeutic Systems (TTS) Revenue by Region (2017-2022) & (USD Million)
Table 145. Asia-Pacific Transdermal Therapeutic Systems (TTS) Revenue by Region (2023-2028) & (USD Million)
Table 146. Asia-Pacific Transdermal Therapeutic Systems (TTS) Sales by Type (2017-2022) & (M Units)
Table 147. Asia-Pacific Transdermal Therapeutic Systems (TTS) Sales by Type (2023-2028) & (M Units)
Table 148. Asia-Pacific Transdermal Therapeutic Systems (TTS) Sales by Application (2017-2022) & (M Units)
Table 149. Asia-Pacific Transdermal Therapeutic Systems (TTS) Sales by Application (2023-2028) & (M Units)
Table 150. South America Transdermal Therapeutic Systems (TTS) Sales by Country (2017-2022) & (M Units)
Table 151. South America Transdermal Therapeutic Systems (TTS) Sales by Country (2023-2028) & (M Units)
Table 152. South America Transdermal Therapeutic Systems (TTS) Revenue by Country (2017-2022) & (USD Million)
Table 153. South America Transdermal Therapeutic Systems (TTS) Revenue by Country (2023-2028) & (USD Million)
Table 154. South America Transdermal Therapeutic Systems (TTS) Sales by Type (2017-2022) & (M Units)
Table 155. South America Transdermal Therapeutic Systems (TTS) Sales by Type (2023-2028) & (M Units)
Table 156. South America Transdermal Therapeutic Systems (TTS) Sales by Application (2017-2022) & (M Units)
Table 157. South America Transdermal Therapeutic Systems (TTS) Sales by Application (2023-2028) & (M Units)
Table 158. Middle East & Africa Transdermal Therapeutic Systems (TTS) Sales by Region (2017-2022) & (M Units)
Table 159. Middle East & Africa Transdermal Therapeutic Systems (TTS) Sales by Region (2023-2028) & (M Units)
Table 160. Middle East & Africa Transdermal Therapeutic Systems (TTS) Revenue by Region (2017-2022) & (USD Million)
Table 161. Middle East & Africa Transdermal Therapeutic Systems (TTS) Revenue by Region (2023-2028) & (USD Million)
Table 162. Middle East & Africa Transdermal Therapeutic Systems (TTS) Sales by Type (2017-2022) & (M Units)
Table 163. Middle East & Africa Transdermal Therapeutic Systems (TTS) Sales by Type (2023-2028) & (M Units)
Table 164. Middle East & Africa Transdermal Therapeutic Systems (TTS) Sales by Application (2017-2022) & (M Units)
Table 165. Middle East & Africa Transdermal Therapeutic Systems (TTS) Sales by Application (2023-2028) & (M Units)
Table 166. Transdermal Therapeutic Systems (TTS) Raw Material
Table 167. Key Manufacturers of Transdermal Therapeutic Systems (TTS) Raw Materials
Table 168. Direct Channel Pros & Cons
Table 169. Indirect Channel Pros & Cons
Table 170. Transdermal Therapeutic Systems (TTS) Typical Distributors
Table 171. Transdermal Therapeutic Systems (TTS) Typical Customers
List of Figures
Figure 1. Transdermal Therapeutic Systems (TTS) Picture
Figure 2. Global Transdermal Therapeutic Systems (TTS) Revenue Market Share by Type in 2021
Figure 3. Methyl Salicylate
Figure 4. Nitroglycerin
Figure 5. Fentanyl
Figure 6. Nicotine
Figure 7. Rivastigmine
Figure 8. Estradiol
Figure 9. Others
Figure 10. Global Transdermal Therapeutic Systems (TTS) Revenue Market Share by Application in 2021
Figure 11. OTC Channel
Figure 12. Retail Channel
Figure 13. E-Commerce Channel
Figure 14. Global Transdermal Therapeutic Systems (TTS) Revenue, (USD Million) & (M Units): 2017 & 2021 & 2028
Figure 15. Global Transdermal Therapeutic Systems (TTS) Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Transdermal Therapeutic Systems (TTS) Sales (2017-2028) & (M Units)
Figure 17. Global Transdermal Therapeutic Systems (TTS) Price (2017-2028) & (USD/K Units)
Figure 18. Global Transdermal Therapeutic Systems (TTS) Production Capacity (2017-2028) & (M Units)
Figure 19. Global Transdermal Therapeutic Systems (TTS) Production Capacity by Geographic Region: 2022 VS 2028
Figure 20. Transdermal Therapeutic Systems (TTS) Market Drivers
Figure 21. Transdermal Therapeutic Systems (TTS) Market Restraints
Figure 22. Transdermal Therapeutic Systems (TTS) Market Trends
Figure 23. Global Transdermal Therapeutic Systems (TTS) Sales Market Share by Manufacturer in 2021
Figure 24. Global Transdermal Therapeutic Systems (TTS) Revenue Market Share by Manufacturer in 2021
Figure 25. Transdermal Therapeutic Systems (TTS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 26. Top 3 Transdermal Therapeutic Systems (TTS) Manufacturer (Revenue) Market Share in 2021
Figure 27. Top 6 Transdermal Therapeutic Systems (TTS) Manufacturer (Revenue) Market Share in 2021
Figure 28. Global Transdermal Therapeutic Systems (TTS) Sales Market Share by Region (2017-2028)
Figure 29. Global Transdermal Therapeutic Systems (TTS) Revenue Market Share by Region (2017-2028)
Figure 30. North America Transdermal Therapeutic Systems (TTS) Revenue (2017-2028) & (USD Million)
Figure 31. Europe Transdermal Therapeutic Systems (TTS) Revenue (2017-2028) & (USD Million)
Figure 32. Asia-Pacific Transdermal Therapeutic Systems (TTS) Revenue (2017-2028) & (USD Million)
Figure 33. South America Transdermal Therapeutic Systems (TTS) Revenue (2017-2028) & (USD Million)
Figure 34. Middle East & Africa Transdermal Therapeutic Systems (TTS) Revenue (2017-2028) & (USD Million)
Figure 35. Global Transdermal Therapeutic Systems (TTS) Sales Market Share by Type (2017-2028)
Figure 36. Global Transdermal Therapeutic Systems (TTS) Revenue Market Share by Type (2017-2028)
Figure 37. Global Transdermal Therapeutic Systems (TTS) Price by Type (2017-2028) & (USD/K Units)
Figure 38. Global Transdermal Therapeutic Systems (TTS) Sales Market Share by Application (2017-2028)
Figure 39. Global Transdermal Therapeutic Systems (TTS) Revenue Market Share by Application (2017-2028)
Figure 40. Global Transdermal Therapeutic Systems (TTS) Price by Application (2017-2028) & (USD/K Units)
Figure 41. North America Transdermal Therapeutic Systems (TTS) Sales Market Share by Type (2017-2028)
Figure 42. North America Transdermal Therapeutic Systems (TTS) Sales Market Share by Application (2017-2028)
Figure 43. North America Transdermal Therapeutic Systems (TTS) Sales Market Share by Country (2017-2028)
Figure 44. North America Transdermal Therapeutic Systems (TTS) Revenue Market Share by Country (2017-2028)
Figure 45. United States Transdermal Therapeutic Systems (TTS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Transdermal Therapeutic Systems (TTS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Transdermal Therapeutic Systems (TTS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Transdermal Therapeutic Systems (TTS) Sales Market Share by Type (2017-2028)
Figure 49. Europe Transdermal Therapeutic Systems (TTS) Sales Market Share by Application (2017-2028)
Figure 50. Europe Transdermal Therapeutic Systems (TTS) Sales Market Share by Country (2017-2028)
Figure 51. Europe Transdermal Therapeutic Systems (TTS) Revenue Market Share by Country (2017-2028)
Figure 52. Germany Transdermal Therapeutic Systems (TTS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Transdermal Therapeutic Systems (TTS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Transdermal Therapeutic Systems (TTS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Transdermal Therapeutic Systems (TTS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Transdermal Therapeutic Systems (TTS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Transdermal Therapeutic Systems (TTS) Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Transdermal Therapeutic Systems (TTS) Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Transdermal Therapeutic Systems (TTS) Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Transdermal Therapeutic Systems (TTS) Revenue Market Share by Region (2017-2028)
Figure 61. China Transdermal Therapeutic Systems (TTS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Transdermal Therapeutic Systems (TTS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Korea Transdermal Therapeutic Systems (TTS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Transdermal Therapeutic Systems (TTS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Transdermal Therapeutic Systems (TTS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Transdermal Therapeutic Systems (TTS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Transdermal Therapeutic Systems (TTS) Sales Market Share by Type (2017-2028)
Figure 68. South America Transdermal Therapeutic Systems (TTS) Sales Market Share by Application (2017-2028)
Figure 69. South America Transdermal Therapeutic Systems (TTS) Sales Market Share by Country (2017-2028)
Figure 70. South America Transdermal Therapeutic Systems (TTS) Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Transdermal Therapeutic Systems (TTS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Transdermal Therapeutic Systems (TTS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East & Africa Transdermal Therapeutic Systems (TTS) Sales Market Share by Type (2017-2028)
Figure 74. Middle East & Africa Transdermal Therapeutic Systems (TTS) Sales Market Share by Application (2017-2028)
Figure 75. Middle East & Africa Transdermal Therapeutic Systems (TTS) Sales Market Share by Region (2017-2028)
Figure 76. Middle East & Africa Transdermal Therapeutic Systems (TTS) Revenue Market Share by Region (2017-2028)
Figure 77. Turkey Transdermal Therapeutic Systems (TTS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Egypt Transdermal Therapeutic Systems (TTS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Transdermal Therapeutic Systems (TTS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. South Africa Transdermal Therapeutic Systems (TTS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Manufacturing Cost Structure Analysis of Transdermal Therapeutic Systems (TTS) in 2021
Figure 82. Manufacturing Process Analysis of Transdermal Therapeutic Systems (TTS)
Figure 83. Transdermal Therapeutic Systems (TTS) Industrial Chain
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
Figure 85. Methodology
Figure 86. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の経皮治療システム（TTS）市場2022年：サリチル酸メチル、ニトログリセリン、フェンタニル、ニコチン、リバスチグミン、エストラジオール、その他(Global Transdermal Therapeutic Systems (TTS) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の経皮治療システム（TTS）市場2022年：サリチル酸メチル、ニトログリセリン、フェンタニル、ニコチン、リバスチグミン、エストラジオール、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp